Comparison of efficacy and safety between VKAs and DOACs in patients with atrial fibrillation after transcatheter aortic valve replacement: A systematic review and meta‐analysis

In the past decade, direct oral anticoagulants (DOACs) have proven to be the best option for patients with nonvalvular atrial fibrillation. Nevertheless, evidence for the use of DOACs for anticoagulation in valvular atrial fibrillation, particularly after aortic valve replacement, remains inadequate...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Jie, Liu, Ming, Zhang, Yu, Yang, Danning, An, Fengshuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574758/
https://www.ncbi.nlm.nih.gov/pubmed/36030549
http://dx.doi.org/10.1002/clc.23909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574758/
https://www.ncbi.nlm.nih.gov/pubmed/36030549
http://dx.doi.org/10.1002/clc.23909

Ejemplares similares